Promising Phase 3 Results for Ameluz® in Treating Superficial Basal Cell Carcinoma
– Introduction to Biofrontera and sBCC Study
– Significance of Phase 3 PDT Study
– Detailed Results of the Study
– Comparison to European sBCC Data
– The Prevalence of BCC in the United States
– Broader Implications for Skin Cancer Treatment
– Conclusion and Future of Biofrontera’s Research
– Call to Action for Awareness and Prevention